skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Conjunto de Dados remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
An Open-label Primary Vaccination Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Three-dose Primary Vaccination Course at 2, 3 and 4 Months of Age in Healthy Infants in China
An Open-label Primary Vaccination Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Three-dose Primary Vaccination Course at 2, 3 and 4 Months of Age in Healthy Infants in China
Material Type:
Dataset 		Adicionar ao Meu Espaço

An Open-label Primary Vaccination Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Three-dose Primary Vaccination Course at 2, 3 and 4 Months of Age in Healthy Infants in China

GlaxoSmithKline

Vivli 2018

Sem texto completo

Citações Citado por
2
An Open-label Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Booster Dose at 18-24 Months of Age in Healthy Toddlers in China
An Open-label Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Booster Dose at 18-24 Months of Age in Healthy Toddlers in China
Material Type:
Dataset 		Adicionar ao Meu Espaço

An Open-label Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Inactivated Poliomyelitis Vaccine Poliorix Administered as a Booster Dose at 18-24 Months of Age in Healthy Toddlers in China

GlaxoSmithKline

Vivli 2018

Sem texto completo

Citações Citado por
3
A Randomized, Observer-Blind, Controlled Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses of a Stand-alone Trivalent, Inactivated Poliomyelitis Vaccine From Sabin Strains in Healthy Infants, With a Safety and Tolerability Age-Step Down Lead-in in Healthy Adults Followed by Healthy Toddlers
A Randomized, Observer-Blind, Controlled Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses of a Stand-alone Trivalent, Inactivated Poliomyelitis Vaccine From Sabin Strains in Healthy Infants, With a Safety and Tolerability Age-Step Down Lead-in in Healthy Adults Followed by Healthy Toddlers
Material Type:
Dataset 		Adicionar ao Meu Espaço

A Randomized, Observer-Blind, Controlled Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses of a Stand-alone Trivalent, Inactivated Poliomyelitis Vaccine From Sabin Strains in Healthy Infants, With a Safety and Tolerability Age-Step Down Lead-in in Healthy Adults Followed by Healthy Toddlers

Takeda

Vivli 2020

Sem texto completo

Citações Citado por
4
Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Infanrix Hexa™ (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Infanrix Hexa™ (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Material Type:
Dataset 		Adicionar ao Meu Espaço

Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Infanrix Hexa™ (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

GlaxoSmithKline

Vivli 2021

Sem texto completo

Citações Citado por
5
Immunogenicity and Safety Study of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated Polio-virus and Haemophilus Influenzae Type b Vaccine (Infanrix Hexa™) (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Immunogenicity and Safety Study of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated Polio-virus and Haemophilus Influenzae Type b Vaccine (Infanrix Hexa™) (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Material Type:
Dataset 		Adicionar ao Meu Espaço

Immunogenicity and Safety Study of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated Polio-virus and Haemophilus Influenzae Type b Vaccine (Infanrix Hexa™) (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

GlaxoSmithKline

Vivli 2020

Sem texto completo

Citações Citado por
6
Immunogenicity and Safety of a Booster Dose of GlaxoSmithKline Biologicals' IPV (PoliorixTM) in Healthy Chinese Toddlers
Immunogenicity and Safety of a Booster Dose of GlaxoSmithKline Biologicals' IPV (PoliorixTM) in Healthy Chinese Toddlers
Material Type:
Dataset 		Adicionar ao Meu Espaço

Immunogenicity and Safety of a Booster Dose of GlaxoSmithKline Biologicals' IPV (PoliorixTM) in Healthy Chinese Toddlers

GlaxoSmithKline

Vivli 2018

Sem texto completo

Citações Citado por
7
Polio meeting, 1960
Polio meeting, 1960
Material Type:
Dataset 		Adicionar ao Meu Espaço

Polio meeting, 1960

Mack [Photographer]

University of Southern California Digital Library (USC.DL) 2013

Sem texto completo

Citações Citado por
8
Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix™) in Infants
Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix™) in Infants
Material Type:
Dataset 		Adicionar ao Meu Espaço

Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix™) in Infants

GlaxoSmithKline

Vivli 2018

Sem texto completo

Citações Citado por
9
Polioviren im Abwasser - PIA
Polioviren im Abwasser - PIA
Material Type:
Dataset 		Adicionar ao Meu Espaço

Polioviren im Abwasser - PIA

Koch-Institut, Robert ; Umweltbundesamt

Zenodo 2023

Texto completo disponível

Citações Citado por
10
Inanspruchnahme von Routineimpfungen in Deutschland - Ergebnisse aus der KV-Impfsurveillance
Inanspruchnahme von Routineimpfungen in Deutschland - Ergebnisse aus der KV-Impfsurveillance
Material Type:
Dataset 		Adicionar ao Meu Espaço

Inanspruchnahme von Routineimpfungen in Deutschland - Ergebnisse aus der KV-Impfsurveillance

Rieck, Thorsten ; Feig, Marcel ; Thielemann, Iris ; Steffen, Annika

Zenodo 2024

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (9)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.